0001213900-22-061373.txt : 20221003 0001213900-22-061373.hdr.sgml : 20221003 20221003185231 ACCESSION NUMBER: 0001213900-22-061373 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221001 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLaughlin Gerald W. CENTRAL INDEX KEY: 0001495412 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41160 FILM NUMBER: 221289074 MAIL ADDRESS: STREET 1: 227 WASHINGTON STREET STREET 2: SUITE 200 CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 BROADWAY STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 ownership.xml X0206 3 2022-10-01 0 0001860657 Allarity Therapeutics, Inc. ALLR 0001495412 McLaughlin Gerald W. C/O ALLARITY THERAPEUTICS, INC. 210 BROADWAY, SUITE 201 CAMBRIDGE, MA 02139 1 0 0 0 Stock Options 1.10 2027-10-01 Common Stock 23000 D Pursuant to the Issuer's 2021 Equity Incentive Plan (the "Plan"), the Reporting Person was granted 23,000 non-qualified stock options (the "Options") at the exercise price of $1.10. The Options were granted on October 1, 2022 (the "Grant Date"), and vest 1/36 per month over a three year period commencing as of the Grant Date. The Options were granted to the Reporting Person, who is a non-executive director of the Issuer, in a transaction exempt under Rule 16b-3 to the Reporting Person. /s/ Gerald W. McLaughlin 2022-10-01